Symbol="SEEL"
AssetType="Common Stock"
Name="Seelos Therapeutics Inc"
Description="Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel technologies and therapies for the treatment of central nervous system, respiratory, and other disorders. The company is headquartered in New York, New York."
CIK="1017491"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="11975 EL CAMINO REAL,, SUITE 300, SAN DIEGO,, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="186371000"
EBITDA="-27706000"
PERatio="None"
PEGRatio="None"
BookValue="-0.17"
DividendPerShare="0"
DividendYield="0"
EPS="-0.75"
RevenuePerShareTTM="0.007"
ProfitMargin="0"
OperatingMarginTTM="-81.48"
ReturnOnAssetsTTM="-0.872"
ReturnOnEquityTTM="-5.84"
RevenueTTM="808000"
GrossProfitTTM="-46649000"
DilutedEPSTTM="-0.75"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="3.25"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="421.9"
PriceToBookRatio="15.1"
EVToRevenue="549.68"
EVToEBITDA="-1.338"
Beta="1.989"
num_52WeekHigh="1.65"
num_52WeekLow="0.58"
num_50DayMovingAverage="1.165"
num_200DayMovingAverage="0.904"
SharesOutstanding="121811000"
DividendDate="2019-01-24"
ExDividendDate="None"
symbol="SEEL"
open="1.54"
high="1.60"
low="1.46"
price="1.58"
volume="851606.00"
latest_trading_day="2023-08-01"
previous_close="1.53"
change="0.05"
change_percent="3.2680%"
aroon_positive_momentum_days="69"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="69"
Volume_recent_avg="627540"
Change_recent_avg="0.01"
Delta_recent_avg="0.09"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="0.78"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="69"
Aroon_momentum_negative="31"
image_negative_thumbnail_id_1="1098"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0131.jpeg"
image_negative_thumbnail_id_2="496"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0109.jpeg"
image_neutral_thumbnail_id_1="565"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0034.jpeg"
image_neutral_thumbnail_id_2="549"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_positive_thumbnail_id_1="649"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0059.jpeg"
image_positive_thumbnail_id_2="663"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0045.jpeg"
image_professor_thumbnail_id_1="1192"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
image_professor_thumbnail_id_2="1198"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
